Journal of AdvancedMedical and Dental Sciences Research

Aim: The present study was aimed to evaluate the safety and efficacy of prophylactic parenteral Iron sucrose administration in 5th and 7th trimester month of gestation in preventing anemia at term. Materials and method: This prospective randomized clinical study was conducted after Approval was taken from the institutional Ethical Committee. Written and Informed Consent was obtained from all patients. The investigations were done in all patients at the beginning of the study (CBC, Iron studies, RBS, VDRL, HCV, HIV, HBsAg, routine urine microscopy, analysis of urine, Ultrasound and per abdominal examination that assessed the placental position, any contraction if present, fetus presentation, expected baby weight, FHR). On admission baseline CBC with RBC indices and iron studies was done. Repeat CBC with RBC indices and iron studies was done 2 weeks after giving injection Iron Sucrose. Results: The mean Hb level increased significantly from before giving Injection Iron sucrose to after 2 weeks of Injection Iron sucrose to after 4 weeks of Injection Iron sucrose. Conclusion: According to the findings of our study, the intravenous administration of iron sucrose treatment was a successful method of preventing anemia in pregnant women at term. It is well known that intramuscular preparations are linked to the development of local adverse effects. The adverse effects of the iron sucrose complex intravenous treatment were almost non-existent.